Valuation: H&R GmbH & Co. KGaA

Market Cap 230M 266M 216M 197M 370M 25.48B 375M 2.53B 991M 12.76B 1B 979M 42.46B P/E 2026 *
4.79x
P/E 2027 * 16.8x
Enterprise Value 253M 293M 237M 216M 406M 28.01B 412M 2.78B 1.09B 14.03B 1.1B 1.08B 46.68B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.18x
Free-Float
21.97%
Yield 2026 *
0.81%
Yield 2027 * 0.81%
08-14 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
24/08/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/08/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
15/05/25 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
13/05/25 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/04/25 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
08/04/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
26/03/25 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
1 day+0.32%
1 week+2.32%
Current month+3.00%
1 month-4.04%
3 months+36.73%
6 months+38.57%
Current year+44.06%
1 week 5.86
Extreme 5.86
6.3
1 month 5.74
Extreme 5.74
6.68
Current year 3.91
Extreme 3.91
6.68
1 year 3.91
Extreme 3.91
6.68
3 years 3.23
Extreme 3.23
6.68
5 years 3.23
Extreme 3.23
10.35
10 years 3.23
Extreme 3.23
19.58
Manager TitleAgeSince
Chief Executive Officer 61 31/12/2015
Investor Relations Contact - 31/12/2005
Director TitleAgeSince
Chairman 62 16/04/2012
Director/Board Member 71 30/04/2011
Director/Board Member 69 30/04/2011
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+2.32%+23.11%+22.62% 265M
-0.86%-3.23%+1.82%+24.94% 124B
-3.37%+6.65%+366.82%+199.70% 51.43B
-1.16%-2.99%-13.40%-42.57% 40.11B
+0.12%-3.42%+16.10%-21.98% 33.9B
+0.17%-3.13%+47.65%+67.13% 24.68B
+1.67%+3.49%+22.45%-33.12% 20.6B
+4.46%+4.91%+379.64%+660.22% 19.4B
+0.16%+7.24%+32.45%+368.98% 18.9B
+2.25%-11.77%+57.15%+230.88% 18.01B
Average +0.38%+0.59%+93.38%+147.68% 35.13B
Weighted average by Cap. -0.43%-0.37%+84.70%+102.00%

Financials

2026 *2027 *
Net sales 1.4B 1.62B 1.31B 1.19B 2.24B 155B 2.27B 15.35B 6.01B 77.43B 6.07B 5.94B 258B 1.36B 1.58B 1.28B 1.16B 2.19B 151B 2.22B 14.98B 5.87B 75.59B 5.92B 5.8B 251B
Net income 48.09M 55.71M 45.12M 41.09M 77.27M 5.33B 78.34M 529M 207M 2.67B 209M 205M 8.88B 13.79M 15.97M 12.94M 11.78M 22.15M 1.53B 22.46M 152M 59.42M 765M 59.96M 58.67M 2.55B
Net Debt 22.87M 26.49M 21.45M 19.54M 36.74M 2.53B 37.25M 251M 98.55M 1.27B 99.45M 97.29M 4.22B 8.65M 10.02M 8.12M 7.39M 13.9M 958M 14.09M 95.14M 37.28M 480M 37.62M 36.81M 1.6B
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,688
Date Price Change Volume
17/08/26 6.180 +0.32% 6,060
14/08/26 €6.160 -0.65% 7,318
13/08/26 €6.200 +4.03% 13,119
12/08/26 €5.960 -1.97% 7,692
11/08/26 €6.080 +0.66% 171
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.160EUR
Average target price
7.500EUR
Spread / Average Target
+21.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock